Medical Oncology

, 36:2 | Cite as

Multidisciplinary team in head and neck cancer: a management model

  • F. De FeliceEmail author
  • V. Tombolini
  • M. de Vincentiis
  • G. Magliulo
  • A. Greco
  • V. Valentini
  • A. Polimeni
Review Article


Nowadays, the multidisciplinary team (MDT) is an essential component for oncologic disease management. Its benefit is also extensively recognized in head and neck cancer (HNC) community, due to tumor rarity and complex treatment. A well-defined MDT management serves as a stable point to define the better strategy and offers a chance to optimize HNC clinical outcomes and patient’s quality of life. We explored both mandatory and additional requirements for establishing a high-quality MDT. Then we proposed an example of HNC MDT organization. The aim is to contribute to the best way to systematize HNC care.


Head and neck cancer Multidisciplinary team Quality of life Management Requirements Organization 


Compliance with ethical standards

Conflict of interest

Authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68(1):7–30.CrossRefGoogle Scholar
  2. 2.
    AIOM. AIRTUM. I numeri del cancro in Italia. Il Pensiero Scientifico. 2016.Google Scholar
  3. 3.
    Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, Silverman CL, Raben A, Kim HE, Horwitz EM, Read NE, Harris J, Wu Q, Le QT, Gillison ML. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol. 2015;33(2):156–64.CrossRefGoogle Scholar
  4. 4.
    Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–50.CrossRefGoogle Scholar
  5. 5.
    Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–37.CrossRefGoogle Scholar
  6. 6.
  7. 7.
    De Felice F, Polimeni A, Valentini V, Brugnoletti O, Cassoni A, Greco A, de Vincentiis M, Tombolini V. Radiotherapy controversies and prospective in head and neck cancer: a literature-based critical review. Neoplasia. 2018;20(3):227–32.CrossRefGoogle Scholar
  8. 8.
    National Comprehensive Cancer Network (NCCN). Guidelines Head and Neck Cancers, Version 2.2018. Accessed 9 Sept 2018.
  9. 9. Accessed 9 Sept 2018.
  10. 10.
    Harris JR, Lau H, Surgeoner BV, Chua N, Dobrovolsky W, Dort JC, Kalaydjian E, Nesbitt M, Scrimger RA, Seikaly H, Skarsgard D, Webster MA. Members of the Alberta Provincial Head and Neck Tumour Team. Health care delivery for head-and-neck cancer patients in Alberta: a practice guideline. Curr Oncol. 2014;21(5):e704–14.CrossRefGoogle Scholar
  11. 11.
    Penel N, Valentin F, Giscard S, Vanseymortier L, Beuscart R. General practitioners assessment of a structured report on medical decision making by a regional multidisciplinary cancer committee. Bull Cancer. 2007;94(10):E23–6.Google Scholar
  12. 12. Accessed 9 Sept 2018.
  13. 13. Accessed 9 Sept 2018.
  14. 14. Accessed 9 Sept 2018.
  15. 15.
    De Felice F, de Vincentiis M, Valentini V, Musio D, Mezi S, Lo Mele L, Terenzi V, D’Aguanno V, Cassoni A, Di Brino M, Tenore G, Bulzonetti N, Battisti A, Greco A, Pompa G, Minni A, Romeo U, Cortesi E, Polimeni A, Tombolini V. Follow-up program in head and neck cancer. Crit Rev Oncol Hematol. 2017;113:151–5.CrossRefGoogle Scholar
  16. 16.
    De Felice F, de Vincentiis M, Valentini V, Musio D, Mezi S, Lo Mele L, Della Monaca M, D’Aguanno V, Terenzi V, Di Brino M, Brauner E, Bulzonetti N, Tenore G, Pomati G, Cassoni A, Tombolini M, Battisti A, Greco A, Pompa G, Minni A, Romeo U, Cortesi E, Polimeni A, Tombolini V. Management of salivary gland malignant tumor: the Policlinico Umberto I, “Sapienza” University of Rome Head and Neck Unit clinical recommendations. Crit Rev Oncol Hematol. 2017;120:93–7.CrossRefGoogle Scholar
  17. 17.
    Zeliotis C. Where to next for cancer centre design? Fut Healthcare J. 2017;4(2):142–5.Google Scholar
  18. 18.
    De Felice F, Thomas C, Patel V, Connor S, Michaelidou A, Sproat C, Kwok J, Burke M, Reilly D, McGurk M, Simo R, Lyons A, Oakley R, Jeannon JP, Lei M, Urbano TG. Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy’s and St Thomas’ Head and Neck Cancer Unit experience. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(1):28–34.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of RadiotherapyPoliclinico Umberto I, “Sapienza” University of RomeRomeItaly
  2. 2.Department of Oral and Maxillo Facial SciencesPoliclinico Umberto I “Sapienza” University of RomeRomeItaly
  3. 3.Department of Sense OrgansPoliclinico Umberto I “Sapienza” University of RomeRomeItaly

Personalised recommendations